Oncology
ESMO 2024 – Today’s oncological roots are branching
What could a tree possibly reveal about the European Society for …
19495 items found
News
Lilly ramps up Irish manufacturing investment by $1bn
Eli Lilly has added $1 billion to its investment plan for a new …
News
Syneos Health Communications takes the crown at PM Society Digital Awards
The PM Society Digital Awards 2024, an annual event in the healthcare …
News
Apple AirPods get FDA okay for use as OTC hearing aids
It's known that excessive use of earbuds at high volumes can cause …
News
US puts $25m behind Cellino's cell and tissue printing tech
Cellino Biotech has received funding from the US government to …
R&D
Reducing drug shortages: The power of AI in pharma supply chain management
Drug shortages have long been a challenge in the pharmaceutical …
News
Armed with $100m funding, F2G prepares to refile antifungal
UK biotech F2G has raised $100 million as it prepares to refile its …
News
Starmer says no extra NHS funding without big reforms
UK Prime Minister Keir Starmer has promised the biggest 'reimagining' …
Digital
Changing Faces: Digital and supplier for August 2024
Welcome to the August edition of Changing Faces’ digital and supplier …
R&D
Digital
How measurement technology can advance sleep monitoring in clinical research and practice
As of 2024, more than one-third of American adults don't get enough …
News
Moderna will cut $1.1bn off its annual R&D spend
Moderna is showcasing its R&D pipeline to investors today, but the …
Oncology
ESMO 2024 – Today’s oncological roots are branching
What could a tree possibly reveal about the European Society for Medical Oncology (ESMO)?
R&D
Sponsored
Beyond clinical: Boosting recruitment and retention with SDO...
The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.
Market Access
Rare diseases: the urgent need for health equity and acceler...
Rare diseases are complex, but the need is urgent. Alexion’s Eunice Alvazzi discusses the shared responsibility in achieving access to innovation in rare diseases
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Market Access
Medicare drug pricing negotiations: What comes next?
Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
4th Mitochondrial Dysfunction Drug Development Summit
Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success
R&D
Partner Content
8th Annual Complement-Based Drug Development Summit
Achieving Efficacy & Exploring Indication Expansion for Complement Inhibitors
